These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 8536790

  • 1. Induction of differentiation and enhancement of vincristine sensitivity of human erythroleukemia HEL cells by vesnarinone, a positive inotropic agent.
    Sato S, Tomoyasu S, Okabe-Kado J, Hozumi M, Tsuruoka N, Nakai S, Adachi M, Honma Y.
    Exp Hematol; 1996 Jan; 24(1):37-42. PubMed ID: 8536790
    [Abstract] [Full Text] [Related]

  • 2. Effects of vesnarinone on the bone marrow stromal cell-dependent proliferation and differentiation of HL60 cells in vitro.
    Nabeshima R, Aizawa S, Nakano M, Toyama K, Sugimoto K, Kaidow A, Imai T, Handa H.
    Exp Hematol; 1997 Jun; 25(6):509-15. PubMed ID: 9197329
    [Abstract] [Full Text] [Related]

  • 3. Induction of apoptosis in human choriocarcinoma cell lines by treatment with 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-quinolinone (vesnarinone).
    Isaka K, Fujito A, Sagawa Y, Yudate T, Nishi H, Ito H, Takayama M.
    Oncol Rep; 2002 Jun; 9(6):1299-305. PubMed ID: 12375038
    [Abstract] [Full Text] [Related]

  • 4. Combined treatment of P-gp-positive L1210/VCR cells by verapamil and all-trans retinoic acid induces down-regulation of P-glycoprotein expression and transport activity.
    Sulová Z, Macejová D, Seres M, Sedlák J, Brtko J, Breier A.
    Toxicol In Vitro; 2008 Feb; 22(1):96-105. PubMed ID: 17920233
    [Abstract] [Full Text] [Related]

  • 5. Tributyrin: a prodrug of butyric acid for potential clinical application in differentiation therapy.
    Chen ZX, Breitman TR.
    Cancer Res; 1994 Jul 01; 54(13):3494-9. PubMed ID: 8012972
    [Abstract] [Full Text] [Related]

  • 6. Effects of novel uracil analogs on proliferation and differentiation of human myeloid leukemia cells.
    Makishima M, Honma Y, Hozumi M, Sampi K, Hattori M, Ishikawa I, Ogura H, Motoyoshi K.
    Exp Hematol; 1992 Aug 01; 20(7):879-85. PubMed ID: 1321051
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. An anticancer drug-sensitive murine erythroleukemia clone: implications for the mechanism of action of antineoplastic drugs.
    Dinnen RD, Robinow CF, Ebisuzaki K.
    Cancer Res; 1993 Apr 15; 53(8):1877-82. PubMed ID: 8467509
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Benzodithiophenes induce differentiation and apoptosis in human leukemia cells.
    Jing Y, Hellinger N, Xia L, Monks A, Sausville EA, Zelent A, Waxman S.
    Cancer Res; 2005 Sep 01; 65(17):7847-55. PubMed ID: 16140954
    [Abstract] [Full Text] [Related]

  • 13. Enhancement of anticancer effects of radiation and conventional anticancer agents by a quinolinone derivative, vesnarinone: studies on human gastric cancer tissue xenografts in nude mice.
    Kawai K, Konishi Y, Izumi K, Sato M, Adachi M, Hozumi M.
    Anticancer Res; 1998 Sep 01; 18(1A):405-12. PubMed ID: 9568110
    [Abstract] [Full Text] [Related]

  • 14. Transcriptional activation of cyclin-dependent kinase inhibitor, p21waf1 gene by treatment with a differentiation inducing agent, vesnarinone in a human salivary gland cancer cell line.
    Omotehara F, Nakashiro K, Uchida D, Hino S, Fujimori T, Kawamata H.
    J Exp Clin Cancer Res; 2003 Mar 01; 22(1):57-60. PubMed ID: 12725323
    [Abstract] [Full Text] [Related]

  • 15. The alpha1-adrenergic receptor antagonists, benoxathian and prazosin, induce apoptosis and a switch towards megakaryocytic differentiation in human erythroleukemia cells.
    Fuchs R, Stelzer I, Haas HS, Leitinger G, Schauenstein K, Sadjak A.
    Ann Hematol; 2009 Oct 01; 88(10):989-97. PubMed ID: 19241077
    [Abstract] [Full Text] [Related]

  • 16. Effect of PEG-recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) on growth and differentiation of the HEL cell line.
    Catani L, Gugliotta L, Motta M, Tazzari P, Baravelli S, Tura S.
    Haematologica; 1998 May 01; 83(5):385-91. PubMed ID: 9658720
    [Abstract] [Full Text] [Related]

  • 17. Mutant RAS selectively promotes sensitivity of myeloid leukemia cells to apoptosis by a protein kinase C-dependent process.
    Gallagher AP, Burnett AK, Bowen DT, Darley RL.
    Cancer Res; 1998 May 01; 58(9):2029-35. PubMed ID: 9581849
    [Abstract] [Full Text] [Related]

  • 18. Expression of protease activated receptor 3 (PAR3) is upregulated by induction of megakaryocyte phenotype in human erythroleukemia (HEL) cells.
    Cupit LD, Schmidt VA, Gnatenko DV, Bahou WF.
    Exp Hematol; 2004 Oct 01; 32(10):991-9. PubMed ID: 15504554
    [Abstract] [Full Text] [Related]

  • 19. A plant steroid, diosgenin, a new megakaryocytic differentiation inducer of HEL cells.
    Beneytout JL, Nappez C, Leboutet MJ, Malinvaud G.
    Biochem Biophys Res Commun; 1995 Feb 06; 207(1):398-404. PubMed ID: 7857294
    [Abstract] [Full Text] [Related]

  • 20. Antitumor effect of vesnarinone on human hepatocellular carcinoma cell lines.
    Kubo K, Matsuzaki Y, Kato A, Terai S, Okita K.
    Int J Oncol; 1999 Jan 06; 14(1):41-6. PubMed ID: 9863007
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.